Global Biopreservation Market Research Report By Application (Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, Regenerative Medicine), By Product Type (Biopreservation Media, Freezers, Cryogenic Storage Systems, Accessories), By End User (Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, and Clinics), By Storage Type (Cryopreservation, Controlled Rate Freezing, Ultra-Low Temperature Storage) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)-F

Biopreservation Market Overview

Biopreservation Market Size and Growth

As per MRFR analysis, the Biopreservation Market Size was estimated at 7.1 (USD Billion) in 2023. The Biopreservation Market is expected to grow from 7.44 (USD Billion) in 2024 to 12.4 (USD Billion) by 2035. The Biopreservation Market CAGR (growth rate) is expected to be around 4.75% during the forecast period (2025-2035).

Key Drivers and Trends

The growing demand for efficient techniques to preserve biological samples and cell-based products is fueling the global biopreservation market. The demand for biopreservation solutions is being driven by a number of important causes, including the growing biobank investments and the growing biotechnology industry.

The market is expanding as a result of growing knowledge of the advantages of biopreservation in regenerative medicine and drug development. The effectiveness and safety of maintaining biological materials in a variety of healthcare applications are improved by emerging technology, such as sophisticated cryopreservation methods and the growth of biobanks.

More research may be done on the opportunities in the global biopreservation market. The necessity for conserved biological samples to offer customized treatment options is being driven by the growing demand for personalized medicine. Additionally, developing nations are growing their healthcare systems, which presents a possible market for biopreservation products.

There are more opportunities for market participants to invest in new technologies and products that address these changing needs as a result of research organizations and academic institutions placing an increased emphasis on innovative approaches.

Emerging Trends and Collaborations

Current trends show a move toward environmentally friendly biopreservation techniques that are in line with international environmental objectives. A deliberate attempt to lessen the environmental impact of biopreservation techniques is seen in advancements in biodegradable materials and energy-efficient storage options.

Furthermore, there is a growing emphasis on creating specialized biopreservation solutions as a result of partnerships between pharmaceutical corporations and academic institutions. In terms of safety, cost-effectiveness, and efficacy, this collaborative trend promotes a more successful strategy for developing biopreservation in the global biopreservation market.

The regulatory environment is changing, promoting adherence to strict quality standards and increasingly influencing the global use of biopreservation.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biopreservation Market Drivers

Increasing Demand for Biobanking

The Global Biopreservation Market is experiencing significant growth due to the increasing demand for biobanking services. According to a report from the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), there has been a fourfold increase in biobanks globally over the last decade, with an estimated 10,000 biobanks in existence worldwide currently.

Biobanks are vital for research and development in personalized medicine, which is projected to reach a total market size of around USD 2.8 trillion by 2025. Moreover, organizations such as the National Institutes of Health (NIH) are investing heavily in biobanking initiatives, indicating a robust trend toward the utilization of preserved biological samples for research.

This surge in biobanking not only underscores the necessity of advanced biopreservation techniques but also highlights the potential for continued growth in the Global Biopreservation Market as these technologies become integral to biobank operations.

Rising Prevalence of Chronic Diseases

The Global Biopreservation Market is significantly supported by the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular illnesses. The World Health Organization (WHO) reports that chronic diseases are responsible for approximately 71% of all global deaths annually, amounting to around 41 million nearly every year.

This alarming statistic emphasizes the increasing demand for effective treatments and therapies, necessitating robust biopreservation methods to sustain biological samples for research and drug development.

Biotechnology companies are adapting to these needs, highlighted by the investment strategies of organizations such as Amgen, which target chronic disease therapies. As a result, the Global Biopreservation Market is predicted to expand, fueled by the need for preserved samples crucial to combating the rise in chronic health issues.

Advancements in Biopreservation Technologies

Technology innovations have notably propelled the Global Biopreservation Market. Newer methods, enhancements in cryopreservation, and the use of advanced cryoprotectants are continuously being researched and developed.

Recent patent filings from organizations such as BioLife Solutions and the National Institute of Standards and Technology (NIST) indicate an ongoing commitment to refining these technologies. For instance, BioLife Solutions reported an increase in their cryopreservation product sales by over 30% in the past year, showcasing the demand for innovative preservation solutions.

This technological advancement not only improves the viability of cellular and tissue samples but also attracts investments in the Global Biopreservation Market. Enhanced technologies provide companies a competitive edge, driving market growth as organizations strive to adopt superior techniques for biopreservation.

Regulatory Support for Biopreservation Practices

The regulatory environment surrounding biopreservation practices has become increasingly favorable, contributing positively to the Global Biopreservation Market. Governments across various regions have implemented stringent guidelines to ensure the quality and safety of biopreserved materials.

In the United States, the Food and Drug Administration (FDA) has laid out clear regulations for cellular therapies and biopreservation processes, which have bolstered the public's trust and acceptance.

Furthermore, the Institute for Quality Management in Healthcare (IQMH) noted that compliance with these governmental regulations promotes the adoption of advanced biopreservation methods within clinical settings, particularly within biobanks and research laboratories.

This supportive regulatory landscape not only fosters market confidence but also encourages continuous investment and innovation in biopreservation technologies, driving the expected growth of the Global Biopreservation Market.

Biopreservation Market Segment Insights

Biopreservation Market Application Insights

The Global Biopreservation Market segmentation focusing on the Application aspect revealed significant insights into its structure and growth potential across several key areas.

The overall market achieved a decent valuation, with distinct applications such as Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, and Regenerative Medicine showcasing varying factors contributing to this growth.

Cell and Tissue Culture

Among these, the Cell and Tissue Culture application dominated the market with a notable valuation of 2.8 USD Billion in 2024, expanding further to 4.3 USD Billion by 2035, driven largely by the increasing demand for biopreserved tissues in therapeutic applications and research settings.

This area was critical as it supported advancements in areas like cancer research and regenerative therapies, significantly affecting patient treatment outcomes.

Gene and Drug Therapy

Gene and Drug Therapy played a vital role, holding a market value of 1.8 USD Billion in 2024, and expected to grow to 3.0 USD Billion by 2035. This application became increasingly important due to breakthroughs in personalized medicine and the necessity for safe and effective storage of bio-specimens for innovative treatments.

Clinical Applications

Clinical Applications were valued at 2.34 USD Billion in 2024, projected to rise to 3.9 USD Billion by 2035, underlining the increasing reliance on biopreservation techniques to maintain the integrity of clinical samples and enhance the efficacy of diagnostic tests.

Regenerative Medicine

Lastly, the Regenerative Medicine application, while comparatively smaller, with a valuation of 0.5 USD Billion in 2024 and anticipated growth to 1.2 USD Billion by 2035, represented an important frontier in medicine, reflecting the growing interest in stem cell therapies and tissue engineering solutions.

Together, these applications painted a comprehensive picture of the Global Biopreservation Market revenue, with each segment reflecting unique growth drivers and opportunities alongside typical challenges like regulatory compliance and quality assurance.

The overall Global Biopreservation Market Statistics indicated a robust and promising trajectory, responding to urgent healthcare needs and technological advancements within the industry, cementing its status as a significant contributor to modern medical practices and research endeavors.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biopreservation Market Product Type Insights

Key categories within this market include Biopreservation Media, Freezers, Cryogenic Storage Systems, and Accessories, each playing a critical role in ensuring the effective preservation of biological materials. Biopreservation Media is integral for maintaining cell integrity during storage, while Freezers provide essential long-term storage solutions across various applications.

Cryogenic Storage Systems are particularly significant due to their ability to preserve cells, tissues, and organs at ultra-low temperatures, thereby ensuring viability for future use. Accessories, although often overlooked, support the functionality and efficiency of the primary systems.

The Global Biopreservation Market statistics showcase that advancements in technology and rising healthcare expenditures are major growth drivers. However, challenges, including stringent regulatory environments and high initial costs, may affect market dynamics.

Overall, the continuous evolution in the Global Biopreservation Market presents ample opportunities for innovation and growth, thereby solidifying its importance in the healthcare landscape.

Biopreservation Market End User Insights

The Global Biopreservation Market shows considerable potential across various End-user sectors, specifically encompassing Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, and Clinics.

These End Users are positioned to significantly impact market growth. Biotechnology companies are central to the development and commercialization of biopreservation techniques, while Pharmaceutical companies leverage these methods for drug development and safety storage, reinforcing their dominance.

Research Institutions contribute to advancements through innovative methodologies and studies, ensuring the field remains adaptive and evolving. Hospitals and Clinics benefit from biopreservation methods to maintain biological samples and improve patient outcomes, thus holding a critical position in the healthcare continuum.

As growth drivers, increased demand for organ transplants and stem cell therapies intensify the necessity for effective biopreservation solutions across these sectors.

The Global Biopreservation Market segmentation reveals these End Users as fundamental contributors, paving the way for improved strategies and methodologies, ultimately addressing the challenges and opportunities inherent in biopreservation practices on a global scale.

Biopreservation Market Storage Type Insights

The Global Biopreservation Market revolves around various storage types, with advancements in technologies greatly influencing growth in this area. The storage type segment primarily includes Cryopreservation, Controlled Rate Freezing, and Ultra-Low Temperature Storage, each playing a crucial role in preserving biological materials.

Cryopreservation is pivotal for the long-term storage of cells and tissues, contributing significantly to Research and Development in regenerative medicine and cell therapy. Controlled Rate Freezing, on the other hand, ensures that cells remain viable during the freezing process, thus preventing ice crystal formation and related damage.

Ultra-Low Temperature Storage enables the safe preservation of sensitive biological components, maintaining their integrity over extended periods. Together, these storage types addressed the growing needs of the pharmaceutical and biotechnology industries, driven by the increasing demand for biobanks and other related services.

The Global Biopreservation Market segmentation reflects these trends, underscoring the importance of innovative storage solutions that cater to the ever-evolving requirements of biological research and therapeutic advancements.

Biopreservation Market Regional Insights

The Global Biopreservation Market showed significant regional variations, with North America holding the largest share valued at 3.0 USD Billion in 2024 and projected to grow to 5.0 USD Billion by 2035, primarily driven by technological advancements and a well-established healthcare infrastructure.

Europe followed with a valuation of 2.0 USD Billion in 2024, expected to reach 3.5 USD Billion in 2035, reflecting a robust demand for biopreservation solutions amidst stringent regulatory standards. The APAC region, valued at 1.5 USD Billion in 2024 and 2.5 USD Billion in 2035, expanded rapidly due to increasing investments in healthcare and rising awareness of biopreservation techniques.

South America, with an initial valuation of 0.6 USD Billion in 2024, is projected to grow to 1.0 USD Billion by 2035, driven by improvements in health infrastructure and research initiatives. The Middle East and Africa (MEA) market, though smaller at 0.34 USD Billion in 2024, anticipates growth to 0.4 USD Billion by 2035, backed by government support for healthcare innovations.

These figures underlined the diverse opportunities within the Global Biopreservation Market, where regional demands shape market growth and development.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biopreservation Market Key Players and Competitive Insights

The Global Biopreservation Market is characterized by a rapidly evolving landscape, marked by increasing demand for biopreserved materials across various sectors, particularly in pharmaceuticals, biotechnology, and healthcare. As organizations strive to ensure the longevity and stability of biological samples, the competition among leading players intensifies.

Technological advancements in cryopreservation, liquid nitrogen storage, and bio-banking solutions are pivotal in shaping the market dynamics. Companies are continuously innovating their product offerings, expanding their service capabilities, and establishing strategic partnerships to enhance their position in the market.

The interplay between regional developments and global trends plays a significant role in influencing competitive strategies, with manufacturers focusing heavily on research and development to address the challenges of maintaining sample integrity.

Panasonic Healthcare

Panasonic Healthcare stands as a significant competitor in the Global Biopreservation Market, leveraging its expertise in advanced cold storage solutions. The company’s offerings include a range of refrigerators and freezers specifically designed for biopreservation applications, playing a critical role in preserving biological materials.

With a strong emphasis on cutting-edge technology, Panasonic Healthcare ensures the reliability and efficiency of its products, ultimately supporting the healthcare and pharmaceutical industries in maintaining the quality of their samples.

Their global presence, strengthened by extensive distribution networks and partnerships, allows Panasonic Healthcare to cater to a diverse clientele, from research institutions to large-scale pharmaceutical companies. The company’s commitment to innovation, coupled with its robust customer support framework, reinforces its competitive edge in this dynamic market.

Fujifilm Irvine Scientific

Fujifilm Irvine Scientific plays a crucial role in the Global Biopreservation Market by providing tailored solutions for cell culture and biopreservation needs. The company specializes in advanced cell therapies and media formulations that are essential for biopreservation and regenerative medicine.

With a strong focus on innovation, Fujifilm Irvine Scientific continues to develop key products that enhance the quality and efficacy of biopreserved cells and tissues. Their strategic mergers and acquisitions have bolstered their position, allowing for the integration of new technologies and expanding their product portfolio.

As a result, Fujifilm Irvine Scientific has established a solid market presence, catering to both research and clinical applications globally. The company’s strengths lie in its ability to deliver high-quality products while maintaining compliance with international regulatory standards, making it a trusted partner in the biopreservation sector.

Key Companies in the Biopreservation Market Include

• Panasonic Healthcare


• Fujifilm Irvine Scientific


• Sartorius AG


• Cryoport, Inc.


• Thermo Fisher Scientific


• Merck KGaA


• Biolife Solutions


• Danaher Corporation


• VWR International


• Sigma-Aldrich


• Celerion


• Wuxi AppTec


• Revvity


• Lonza Group


• Streck, Inc.

Biopreservation Market Developments

The Global Biopreservation Market has seen significant developments recently, especially regarding advancements in genetic therapies and the preservation of stem cells. In September 2023, Thermo Fisher Scientific announced a strategic collaboration with Lonza Group to enhance biopreservation techniques, enabling better storage solutions for advanced therapies.

Companies like Fujifilm Irvine Scientific and Merck KGaA are also focusing on innovative preservation products for cell and gene therapies, addressing the rising demand in the healthcare sector. In terms of financial growth, Cryoport Inc. reported a substantial increase in market valuation due to the rising adoption of biopreservation techniques in clinical applications.

Over the past few years, notable mergers such as Sartorius AG acquiring the bioprocessing division of Danaher Corporation in June 2022 have reshaped the competitive landscape. This evolving market is driven by the increasing need for robust biopreservation solutions, with major players like Biolife Solutions and VWR International improving their product offerings, thus enhancing their market presence.

The Global Biopreservation Market is expected to continue growing as technological advancements and strategic collaborations pave the way for enhanced solutions in biobanking and regenerative medicine.

Biopreservation Market Segmentation Insights

Biopreservation Market Application Outlook

• Cell and Tissue Culture


• Gene and Drug Therapy


• Clinical Applications


• Regenerative Medicine

Biopreservation Market Product Type Outlook

• Biopreservation Media


• Freezers


• Cryogenic Storage Systems


• Accessories

Biopreservation Market End User Outlook

• Biotechnology Companies


• Pharmaceutical Companies


• Research Institutions


• Hospitals and Clinics

Biopreservation Market Storage Type Outlook

• Cryopreservation


• Controlled Rate Freezing


• Ultra-Low Temperature Storage

Biopreservation Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	7.1(USD Billion)
MARKET SIZE 2024	7.44(USD Billion)
MARKET SIZE 2035	12.4(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.75% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Panasonic Healthcare, Fujifilm Irvine Scientific, Sartorius AG, Cryoport, Inc., Thermo Fisher Scientific, Merck KGaA, Biolife Solutions, Danaher Corporation, VWR International, SigmaAldrich, Celerion, Wuxi AppTec, Revvity, Lonza Group, Streck, Inc.
SEGMENTS COVERED	Application, Product Type, End User, Storage Type, Regional
KEY MARKET OPPORTUNITIES	Increased demand for organ transplants, Growing biobanking initiatives, Rising prevalence of chronic diseases, Advancements in preservation technologies, Expansion of personalized medicine programs
KEY MARKET DYNAMICS	Increasing demand for organ transplants, Growing focus on biobanking, Advancements in preservation technologies, Rising investments in biopreservation research, Stringent regulatory frameworks
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA